May 8, 2023
Life Sciences | Tea Leaves
  • As U.S. health regulators are weighing thefirst-ever request to make a birth control pill available without a prescription, Food and Drug Administration (FDA) scientists on Friday expressed skepticism about whether the birth control pill can be switched from prescription to over-the-counter. In its review of drugmaker Perrigo’s application for Opill, the FDA cited problems with the reliability of some of the company’s data on the drug and questioned whether women with certain other medical conditions would correctly opt out of taking it. The agency also noted signs that study participants had trouble understanding the labeling instructions. (Articles here and here)